Excerpt: There is likely to be some overhang risk associated with HYBE's remaining stake in…
Smartkarma NewswireMay 28, 2024
Press Mentions
Smartkarma Mentions In Leading Financial Press
The clinical data for the drug ivonescimab — also known as AK112 — missed expectations,…
Smartkarma NewswireMay 24, 2024
NSCLC progressed after EGFR-TKI treatment) missed expectations,” analyst Criss Wang wrote in a note on…
Smartkarma NewswireMay 24, 2024
Excerpt: multi-purpose vehicle (MPV), which the company is now also selling at a discount, has…
Smartkarma NewswireMay 21, 2024
inclusions for the underweighted healthcare industry,” Brian Freitas, founder of Periscope Analytics who publishes on…
Smartkarma NewswireMay 17, 2024
sized deals in the country, according to Douglas Kim, an analyst who published on the…
Smartkarma NewswireMay 15, 2024
Excerpt: EXECUTIVE SUMMARY The Smartkarma Corporate Webinar | Sasseur REIT: A Glimpse into China's Outlet…
Smartkarma NewswireMay 15, 2024
Excerpt: … a huge financial burden for SoftBank to acquire Naver's entire stake considering its…
Smartkarma NewswireMay 14, 2024
on media reports of investment in AI chips, but no announcement was made and the…
Smartkarma NewswireMay 14, 2024
Excerpt: LightStream Research analyst Mio Kato, who publishes on investment research platform Smartkarma, described that…
Smartkarma NewswireMay 10, 2024
Excerpt: Although Naver could use legal or political means to try to hold on to…
Smartkarma NewswireMay 10, 2024
Explore our Solutions
Discover how decision-makers utilise the Smartkarma Platform to surface actionable insight, engage top-analysts and subscribe to premium data add-ons
For Institutional Investors & Financial Services
Asset Managers
Private Markets
Investment and Corporate Banking
For Corporate IR & Strategy
Investor Relations
Corporate Strategy & M&A
Marketing & Thought Leadership
